Journal of Clinical Epidemiology
Volume 53, Issue 9 , Pages 920-930 , September 2000

Construction of the Patient-Oriented Prostate Utility Scale (PORPUS) a multiattribute health state classification system for prostate cancer

  • Murray Krahn

      Affiliations

    • Departments of Medicine, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Program in Clinical Epidemiology and Health Care Research, University of Toronto, Toronto, Ontario, Canada,
    • Corresponding Author InformationCorresponding author. The Toronto General Hospital, ENG-248, Toronto, Ontario M5G 2C4. Tel: 416-340-4155; fax: 416-595-5826.
    • ,
  • Paul Ritvo

      Affiliations

    • Departments of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Psychiatry, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Surgery, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada,
    • Division of Epidemiology, Biostatistics and Behavioral Science and, Cancer Care Ontario, Toronto, Ontario, Canada
    • Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario, Canada
    • ,
  • Jane Irvine

      Affiliations

    • Departments of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Psychiatry, University of Toronto, Toronto, Ontario, Canada,
    • ,
  • George Tomlinson

      Affiliations

    • Departments of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada,
    • ,
  • Andrea Bezjak

      Affiliations

    • Departments of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Program in Clinical Epidemiology and Health Care Research, University of Toronto, Toronto, Ontario, Canada,
    • ,
  • John Trachtenberg

      Affiliations

    • Departments of Surgery, University of Toronto, Toronto, Ontario, Canada,
    • ,
  • Gary Naglie

      Affiliations

    • Departments of Medicine, University of Toronto, Toronto, Ontario, Canada,
    • Departments of Program in Clinical Epidemiology and Health Care Research, University of Toronto, Toronto, Ontario, Canada,

Received 23 July 1999 ,Revised 15 December 1999 ,Accepted 26 January 2000.

References 

  1. Williams A. The measurement and valuation of health: a chronicle. Discussion paper 136. York, Great Britain: Centre for Health Economics, University of York, 1995.
  2. Elvik R. The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc Sci Med. 1996;40:1385–1398
  3. Sculpher MJ, Dwyer N, Byford S, Stirrat GM. Randomised trial comparing hysterectomy and transcervical endometrial resection (effect on health related quality of life and costs two years after surgery). Br J Obstet Gynaecol. 1996;103:142–149
  4. Hollingworth W, Mackenzie R, Todd CJ, Dixon AK. Measuring changes in quality of life following magnetic resonance imaging of the knee (SF-36, EuroQol, or Rosser Index). Qual Life Res. 1995;4:325–334
  5. Barr RD, Furlong W, Dawson S. An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol. 1993;15:284–290
  6. Saigal S, Rosenbaum P, Stoskopf B. Comprehensive assessment of the health status of extremely low birthweight children at eight years of age (comparison with a reference group). J Pediatr. 1994;125:411–417
  7. Statistics Canada . Health Status of Canadians (Report of the 1991 General Social Survey). Ottawa: Statistics Canada; 1994;
  8. Patrick DL, Bush JW, Chen MM. Toward an operational definition of health. J Health Soc Behav. 1973;14:6–23
  9. Kaplan RM, Anderson JP. A general health policy model (update and applications). Health Services Res. 1988;23:203–235
  10. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life Res. 1993;2:467–475
  11. Dolan P. Modeling valuations for EuroQol Health States. Med Care. 1997;35:1095–1108
  12. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems (Health Utilities Index). Pharamacoeconomics. 1995;7:490–502
  13. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions (Health Utilities Index). Pharmacoeconomics. 1995;7:503–520
  14. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis. 1987;40:593–600
  15. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Economics. 1986;5:1–30
  16. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Tech Assoc Health Care. 1989;5:559–575
  17. Sintonen H. An approach to measuring and valuing health states. Soc Sci Med. 1981;15:55–65
  18. Mohide EA, Torrance GW, Streiner DL, Pringle DM, Gilbert R. Measuring the well being of family caregivers using the time trade-off technique. J Clin Epi. 1988;41:475–482
  19. Bennett KJ, Torrance GW, Moran LA, Smith F, Goldsmith CH. Health State Utilities in Knee Replacement Surgery (the development and validation of McKnee). Journal of Rheumatology. 1997;24:1796–1805
  20. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer (a decision analytic view). JAMA. 1994;272:781–786
  21. Cantor SB, Spann SJ, Volk RJ, Cardenas MP, Warren MM. Prostate cancer screening (a decision analysis). J Fam Pract. 1995;41:33–41
  22. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg J. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 1993;269:2650–2659
  23. Essink-Bot ML, Stouthard ME, Bonsel GJ. Generalizability of valuations on health states collected with the EuroQol questionnaire. Health Economics. 1993;2:237–246
  24. Kaplan RM, Anderson JP, Wu AW, Mathews C, Kozin F, Orenstein D. The Quality of Well-Being scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989;27:S27–s43
  25. Fossa SD, Aaronson N, deVoogt HJ, daSilva FC. Assessment of quality of life and subjective response criteria in patients with prostatic cancer. In: EORTC Genitourinary Group Monograph 7: Prostate Cancer and Testicular Cancer. New York: Wiley-Liss, Inc., 1990. pp. 199–202.
  26. da Silva FC. Quality of life in prostatic cancer patients. Cancer. 1993;72:3803–3806
  27. Fossa SD, Aaronson NK, Newling D, et al.  Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer. 1990;26:1133–1136
  28. Parmar H, Phillips RH, Lightman SL, Edwards L. How would you like to have an orchidectomy for advanced prostatic cancer. Am J Clin Oncol. 1988;11(suppl.2):160–168
  29. Villavicencio H. Quality of life of patients with advanced and metastatic prostatic carcinoma. European Urology. 1993;24(suppl. 2):118–121
  30. Cassileth BR, Soloway MS, Vogelzang NJ, et al.  Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res. 1992;1:323–330
  31. Herr H, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer. 1993;71:1143–1150
  32. Pedersen KV, Carlsson P, Rahmquist M, Varenhorst E. Quality of life after radical retropubic prostatectomy for carcinoma of the prostate. Eur Urol. 1993;35:7–11
  33. Litwin MS, Fink A, Hays RD, et al.  Quality of life in men with prostate cancer (a pilot study). J Urol. 1993;149:494A
  34. Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer. 1994;73:2791–2802
  35. Herr HW. Quality of life of incontinent men after radical prostatectomy. J Urol. 1994;151:652–654
  36. Payne R. Pain management in the patient with prostate cancer. Cancer. 1993;71:1131–1137
  37. Litwin MS, Hays RD, Fink A, et al.  Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135
  38. Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Br J Urol. 1995;75:48–53
  39. Fowler FJ, Barry MJ, Lu-Yao G, Wannson J. Effect of radical prostatectomy for prostate cancer on patient quality of life (results from a Medicare survey). Urology. 1995;45:1007–1013
  40. McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS Short- and Long-Form health status scales and Dartmouth COOP charts. Med Care. 1992;30:MS253, MS265
  41. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36) (II. Psychometric and clinical tests of validity in measuring physical and mental health constructs). Med Care. 1993;31:247–263
  42. McHorney CA, Ware JE, Rachel Lu JFR, Donald Sherbourne C. The MOS 36-item short-form health survey (SF-36) (III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups). Med Care. 1994;32:40–66
  43. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile (subjective health status and medical consultations). Soc Sci Med. 1981;15A:221–228
  44. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile (development and final revision of a health status measure). Med Care. 1981;19:787–805
  45. Ganz PA, Schag CAC, Lee JJ, Sim MS. The cares (a genetic measure of health-related quality of life for patients with cancer). Qual Life Res. 1992;1:19–29
  46. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients (the Functional Living Index-Cancer). J Clin Oncol. 1984;2:472–483
  47. Aaronson NK, Ahmedzai S, Bergman G, et al.  The European Organization for Research and Treatment of Cancer QLQ-C30 (a quality of life instrument for use in international clinical trials in oncology). JNCI. 1993;85:365–376
  48. Gelber RD, Goldhirsch A, Cole BF. Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. Controlled Clin Trials. 1993;14:485–499
  49. Selby PJ, Chapman JAW, Etazadi-Amoli J, Dalley D, Boyd NF. The development of a method for assessing the quality of life of cancer patients. Br J Cancer. 1984;50:13–22
  50. Cella DF, Tulsky DS, Gray G, et al.  The Functional Assessment of Cancer Therapy scale (development and validation of the general measure). J Clin Oncol. 1993;11:570–579
  51. Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S. A brief POMS measure of distress for cancer patients. J Chron Dis. 1987;40:939–942
  52. Stockler M, Osoba D, Goodwin P, Corey P, Tannock IF. Responsiveness to change in health related quality of life (a comparison of the prostate cancer specific quality of life instrument (PROSQOLI) with a modular EORTC instrument in a positive randomized trial). J Clin Epidemiol. 1998;51:137–145
  53. Furlong WH, Torrance GW, Feeny D, Boyle MH. McMaster Health Utilities Index of health-related quality of life. Qual Life Res. 1994;3:76
  54. Van Agt HME, Essink-Bot ML, Krabbe PFM, Bonsel GJ. Test–retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med. 1994;39:1537–1544
  55. Morrison DF. Multivariate Statistical Methods. New York: McGraw-Hill; 1990;
  56. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall; 1993;
  57. Glass GV, Peckham PD, Sanders JR. Consequences of failure to meet assumptions underlying the fixed effects analyses of variance and covariance. In:  Collier RO,  Hummel TJ editor. Experimental Design and Interpretation. Berkeley: McCutchan; 1977;p. 507–565
  58. Miller GA. The magical number seven plus or minus two (some limits on our capacity to process information). Psychol Rev. 1956;63:81–97
  59. Froberg DG, Kane RL. Methodology for measuring health-state preferences-II (scaling methods). J Clin Epidemiol. 1989;42:459–471
  60. Torrance GW, Zhang Y, Feeny D, Furlong W, Barr W. Multi-attribute preference functions for a comprehensive Health Status Classification System, McMaster University Technical Document (Centre for Health Economics and Policy Analysis Working Paper Series, 92–18), 1992.
  61. Cella DF, Tulsky DS. Quality of life in cancer (definition, purpose, and method of measurement). Cancer Invest. 1993;11:327–336
  62. Aaronson NK, Ahmedzai S, Bergman B, et al.  The European Organization for Research and Treatment of Cancer QLQ-C30 (a quality-of-life instrument for use in international clinical trials in oncology). JNCI. 1993;85:365–376
  63. Ware JE, Donald Sherbourne C. The MOS 36-item short-form health survey (SF-36) 1. Conceptual framework and item selection. Med Care. 1992;30:473–481

PII: S0895-4356(00)00211-0

Journal of Clinical Epidemiology
Volume 53, Issue 9 , Pages 920-930 , September 2000

Article Tools

* Image Usage & Resolution